Aktív témák

  • syberia

    veterán

    válasz emvy #4283 üzenetére

    Materials and methods: We analyzed data from a prospective, observational study of the citywide COVID-19 prevention with ivermectin program, which was conducted between July 2020 and December 2020 in Itajaí, Brazil. Study design, institutional review board approval, and analysis of registry data occurred after completion of the program. The program consisted of inviting the entire population of Itajaí to a medical visit to enroll in the program and to compile baseline, personal, demographic, and medical information. In the absence of contraindications, ivermectin was offered as an optional treatment to be taken for two consecutive days every 15 days at a dose of 0.2 mg/kg/day.

    Tehát nem eredeti indikációban, hanem covid megelőzésre adták az ivermektint a tanulmányba bevont lakosságnak, statisztikailag szignifikáns eredményességgel.

    https://howbad.info/

Aktív témák